Home/GlucoSentient/Dr. Steve Mayer
DS

Dr. Steve Mayer

Industry Advisor/Contributor

GlucoSentient

GlucoSentient Pipeline

DrugIndicationPhase
Therapeutic Drug Monitoring PlatformVarious (e.g., Immunosuppressants, Lithium)Pre-clinical
Cardiac Biomarker MonitoringCardiovascular Risk (CRP, BNP)Pre-clinical
Lung Transplant MonitoringPost-Transplant Drug MonitoringPre-clinical
PKU MonitoringPhenylketonuria (Phe Levels)Pre-clinical
Bipolar Disorder MonitoringLithium/Sodium Ion MonitoringPre-clinical